Squarepoint’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,966
| Closed | -$59K | – | 3067 |
|
|
2020
Q3 | $59K | Sell |
25,966
-106,582
| -80% | -$242K | ﹤0.01% | 2191 |
|
|
2020
Q2 | $305K | Buy |
132,548
+118,087
| +817% | +$272K | ﹤0.01% | 1558 |
|
|
2020
Q1 | $25K | Buy |
14,461
+1,639
| +13% | +$2.83K | ﹤0.01% | 1763 |
|
|
2019
Q4 | $27K | Buy |
+12,822
| New | +$27K | ﹤0.01% | 2323 |
|
|
2019
Q3 | – | Sell |
-39,427
| Closed | -$155K | – | 2747 |
|
|
2019
Q2 | $155K | Buy |
39,427
+38,176
| +3,052% | +$150K | ﹤0.01% | 2087 |
|
|
2019
Q1 | $6K | Sell |
1,251
-2,551
| -67% | -$12.2K | ﹤0.01% | 2047 |
|
|
2018
Q4 | $9K | Buy |
3,802
+355
| +10% | +$840 | ﹤0.01% | 1874 |
|
|
2018
Q3 | $21K | Buy |
+3,447
| New | +$21K | ﹤0.01% | 1935 |
|
|
2016
Q3 | – | Sell |
-5,363
| Closed | -$176K | – | 1392 |
|
|
2016
Q2 | $176K | Buy |
+5,363
| New | +$176K | 0.01% | 916 |
|